Bereiding van nystatine aerosol voor paarden

1. The incidence of secondary bronchopulmonary candidiasis has been reported in 3.7 per cent in chronic bronchopulmonary diseases, but primary bronchopulmonary candidiasis is a rare entity.

2. Eleven patients were found to have bronchopulmonary candidiasis of which one had primary pulmonary disease.

3. Only nine patients received treatment and all improved. It is suggested that patients with chronic bronchitis who do not improve with conventional treatment be investigated for bronchopulmonary candidiasis.

4. Suspension of sterilized nystatin powder (50,000 units) daily in divided doses in 40 per cent propylene glycol in normal saline were given as aerosol.

5. Combination of oral nystatin tablets 2,000,000 units daily in four divided doses with aerosol of suspension of nystatin powder (50,000 units in four divided doses) in 40 per cent propylene glycol in normal saline solution with the help of intermittent positive pressure breathing in inspiration at pressure of 10-15 cm of H₂O or with the help of hand nebulizer when positive pressure machine is not available, are recommended. Treatment should be given for at least two to three weeks.